Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • dawe
    Senior Member
    • Apr 2009
    • 258

    #1

    cuffdiff and limma, puzzled by the differences

    Hi all, I've been using cuffdiff for a long time but recently I've given limma (voom) a try for RNA-seq data and compared the results.
    The experiment is quite simple, a triplicate in a treatment vs control experiment (60M read tags for each sample). Cuffdiff finds almost 300 DGE, where limma finds almost 900. Almost 100 are in common between the two.
    I have qPCR control for 3 genes and, according to the fold change, both the approaches are concordant with qPCR data. I understand that this is not an extensive test, but it is what can ben typically done within a lab (I mean, check few genes by qPCR). As a matter of facts, the FPKM quantification and the CPM quantification (cuffdiff vs limma) are quite consistent, the statistical test is making all the difference.
    I've tried some pathway analysis to see if the two approaches are similar from the ontologic point of view... well, this is not really the case (there are some overlapping pathways, of course, but all in all the experiments are saying something different)
    I see that others have tried such comparisons, with different results, now I realise I'm stuck in choosing the proper analysis approach... any hint?

    d
  • DZhang
    Senior Member
    • Jun 2010
    • 177

    #2
    Dawe,

    Depending on what's downstream experiment(s), you may focus on the overlapping 100 genes. (I assume you used the same fold/FDR criteria for both programs.) You may also plot them on a volcano plot to see where most of the overlapping occurs. If it occurs at high folder change and/or low FDR, you may tighten your filtering criteria accordingly to improve the overlap pool.

    Best regards,
    Douglas

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    16 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    17 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    35 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...